 |
OmniSpirant Therapeutics
Last updated: January 28, 2024
Founder Gerry McCauley
Country: Ireland | Funding: €13.4M (+)
Website: https://www.omnispirant.com
Developing first in class regenerative gene therapies. Proprietary OmniSomes technology uses bioengineered stem cell extracellular vesicles (exosomes) as novel delivery vehicles for RNA based advanced therapeutics with regenerative medicine properties.
Website: https://www.omnispirant.com
Developing first in class regenerative gene therapies. Proprietary OmniSomes technology uses bioengineered stem cell extracellular vesicles (exosomes) as novel delivery vehicles for RNA based advanced therapeutics with regenerative medicine properties.
